• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DynaMiTES-用于体外药物测试的动态细胞培养平台 第 1 部分-微流控系统的工程设计和技术模拟。

DynaMiTES - A dynamic cell culture platform for in vitro drug testing PART 1 - Engineering of microfluidic system and technical simulations.

机构信息

Institut für Mikrotechnik, Technische Universität Braunschweig, Alte Salzdahlumer Straße 203, 38124 Braunschweig, Germany; Center of Pharmaceutical Engineering - PVZ, Technische Universität Braunschweig, Franz-Liszt-Straße 35 A, 38106 Braunschweig, Germany.

Institut für Pharmazeutische Technologie, Technische Universität Braunschweig, Mendelssohnstraße 1, 38106 Braunschweig, Germany; Center of Pharmaceutical Engineering - PVZ, Technische Universität Braunschweig, Franz-Liszt-Straße 35 A, 38106 Braunschweig, Germany.

出版信息

Eur J Pharm Biopharm. 2018 May;126:159-165. doi: 10.1016/j.ejpb.2017.04.022. Epub 2017 Apr 22.

DOI:10.1016/j.ejpb.2017.04.022
PMID:28442371
Abstract

Conventional safety and efficacy test models, such as animal experiments or static in vitro cell culture models, can often not reliably predict the most promising drug candidates. Therefore, a novel microfluidic cell culture platform, called Dynamic Micro Tissue Engineering System (DynaMiTES), was designed to allow online analysis of drugs permeating through barrier forming tissues under dynamic conditions combined with monitoring of the transepithelial electrical resistance (TEER) by electrodes optimized for homogeneous current distribution. A variety of pre-cultivated cell culture inserts can be integrated and exposed to well controlled dynamic micro flow conditions, resulting in a tightly regulated exposure of the cells to tested drugs, drug formulations and shear forces. With these qualities, the new system can provide more relevant information compared to static measurements. As a first in vitro model, a three-dimensional hemicornea construct consisting of human keratocytes (HCK-Ca) and epithelial cells (HCE-T) was successfully tested in the DynaMiTES. Thereby, we were able to demonstrate the functionality and cell compatibility of this new organ on chip test platform. The modular design of the DynaMiTES allows fast adaptation suitable for the investigation of drug permeation through other important cellular barriers.

摘要

传统的安全性和功效测试模型,如动物实验或静态体外细胞培养模型,往往不能可靠地预测最有前途的药物候选物。因此,设计了一种新型的微流控细胞培养平台,称为动态微组织工程系统 (DynaMiTES),允许在动态条件下在线分析透过形成屏障的组织的药物,同时通过针对均匀电流分布进行优化的电极监测跨上皮电阻 (TEER)。各种预培养的细胞培养插入物可以集成并暴露于控制良好的动态微流动条件下,从而使细胞受到测试药物、药物制剂和剪切力的严格调节暴露。通过这些特性,新系统可以提供比静态测量更相关的信息。作为第一个体外模型,成功地在 DynaMiTES 中测试了由人角膜细胞 (HCK-Ca) 和上皮细胞 (HCE-T) 组成的三维半角膜构建体。由此,我们能够证明这种新型器官芯片测试平台的功能和细胞相容性。DynaMiTES 的模块化设计允许快速适应适合研究其他重要细胞屏障的药物渗透。

相似文献

1
DynaMiTES - A dynamic cell culture platform for in vitro drug testing PART 1 - Engineering of microfluidic system and technical simulations.DynaMiTES-用于体外药物测试的动态细胞培养平台 第 1 部分-微流控系统的工程设计和技术模拟。
Eur J Pharm Biopharm. 2018 May;126:159-165. doi: 10.1016/j.ejpb.2017.04.022. Epub 2017 Apr 22.
2
DynaMiTES - A dynamic cell culture platform for in vitro drug testing PART 2 - Ocular DynaMiTES for drug absorption studies of the anterior eye.DynaMiTES——用于体外药物测试的动态细胞培养平台 第 2 部分——用于前眼部药物吸收研究的眼部 DynaMiTES。
Eur J Pharm Biopharm. 2018 May;126:166-176. doi: 10.1016/j.ejpb.2017.03.021. Epub 2017 Apr 2.
3
Improved in vitro models for preclinical drug and formulation screening focusing on 2D and 3D skin and cornea constructs.关注 2D 和 3D 皮肤和角膜构建体的药物和制剂筛选的临床前改进的体外模型。
Eur J Pharm Biopharm. 2018 May;126:57-66. doi: 10.1016/j.ejpb.2017.11.014. Epub 2017 Dec 2.
4
Parametric investigation of static and dynamic cell culture conditions and their impact on hCMEC/D3 barrier properties.静态和动态细胞培养条件及其对 hCMEC/D3 屏障特性的影响的参数研究。
Int J Pharm. 2019 Jul 20;566:434-444. doi: 10.1016/j.ijpharm.2019.05.074. Epub 2019 Jun 1.
5
Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.三维肝脏微器官的生物制造作为体外药物代谢模型。
Biofabrication. 2010 Dec;2(4):045004. doi: 10.1088/1758-5082/2/4/045004. Epub 2010 Nov 15.
6
Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro.人角膜的细胞培养模型——对其在体外测定眼部药物吸收实用性的比较评估。
J Pharm Pharmacol. 2008 Mar;60(3):299-307. doi: 10.1211/jpp.60.3.0004.
7
Microfluidic System for In Vivo-Like Drug Permeation Studies with Dynamic Dilution Profiles.用于具有动态稀释曲线的体内样药物渗透研究的微流控系统
Bioengineering (Basel). 2021 May 5;8(5):58. doi: 10.3390/bioengineering8050058.
8
Direct cell writing of 3D microorgan for in vitro pharmacokinetic model.用于体外药代动力学模型的3D微生物的直接细胞书写
Tissue Eng Part C Methods. 2008 Jun;14(2):157-66. doi: 10.1089/ten.tec.2007.0392.
9
Microfluidics-based in vivo mimetic systems for the study of cellular biology.用于细胞生物学研究的基于微流控的体内模拟系统。
Acc Chem Res. 2014 Apr 15;47(4):1165-73. doi: 10.1021/ar4002608. Epub 2014 Feb 20.
10
Parallelizable Microfluidic Platform to Model and Assess In Vitro Cellular Barriers: Technology and Application to Study the Interaction of 3D Tumor Spheroids with Cellular Barriers.可并行化微流控平台用于建模和评估体外细胞屏障:技术及其在研究 3D 肿瘤球体与细胞屏障相互作用中的应用。
Biosensors (Basel). 2021 Sep 3;11(9):314. doi: 10.3390/bios11090314.

引用本文的文献

1
Recent Advances in Studying In Vitro Drug Permeation Across Mucosal Membranes.体外药物透过黏膜膜研究的最新进展
Pharmaceutics. 2025 Feb 14;17(2):256. doi: 10.3390/pharmaceutics17020256.
2
Current microfluidic platforms for reverse engineering of cornea.当前用于角膜逆向工程的微流控平台。
Mater Today Bio. 2023 Apr 11;20:100634. doi: 10.1016/j.mtbio.2023.100634. eCollection 2023 Jun.
3
Development of In Vitro Dry Eye Models to Study Proliferative and Anti-Inflammatory Effects of Allogeneic Serum Eye Drops.开发体外干眼症模型以研究同种异体血清滴眼液的增殖和抗炎作用。
Int J Mol Sci. 2023 Jan 13;24(2):1567. doi: 10.3390/ijms24021567.
4
Developing a transwell millifluidic device for studying blood-brain barrier endothelium.开发一种用于研究血脑屏障内皮细胞的 Transwell 微流控装置。
Lab Chip. 2022 Nov 22;22(23):4603-4620. doi: 10.1039/d2lc00657j.
5
Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing.芯片上的组织屏障:药物测试中可重复实践的一项技术。
Pharmaceutics. 2022 Jul 12;14(7):1451. doi: 10.3390/pharmaceutics14071451.
6
Lipid Nanoparticle Technology for Delivering Biologically Active Fatty Acids and Monoglycerides.脂质纳米颗粒技术在递送生物活性脂肪酸和单甘油脂中的应用。
Int J Mol Sci. 2021 Sep 7;22(18):9664. doi: 10.3390/ijms22189664.
7
Role of In Vitro Models for Development of Ophthalmic Delivery Systems.体外模型在眼科递药系统开发中的作用。
Crit Rev Ther Drug Carrier Syst. 2021;38(3):1-31. doi: 10.1615/CritRevTherDrugCarrierSyst.2021035222.
8
In-Line Analysis of Organ-on-Chip Systems with Sensors: Integration, Fabrication, Challenges, and Potential.基于传感器的芯片上器官系统的在线分析:集成、制造、挑战与潜力。
ACS Biomater Sci Eng. 2021 Jul 12;7(7):2926-2948. doi: 10.1021/acsbiomaterials.0c01110. Epub 2021 Jun 16.
9
Microfluidic System for In Vivo-Like Drug Permeation Studies with Dynamic Dilution Profiles.用于具有动态稀释曲线的体内样药物渗透研究的微流控系统
Bioengineering (Basel). 2021 May 5;8(5):58. doi: 10.3390/bioengineering8050058.
10
Skin-on-a-Chip Device for Ex Vivo Monitoring of Transdermal Delivery of Drugs-Design, Fabrication, and Testing.用于药物透皮递送体外监测的芯片上皮肤装置——设计、制造与测试
Pharmaceutics. 2019 Sep 2;11(9):445. doi: 10.3390/pharmaceutics11090445.